Novo Nordisk Challenges

By The Moscow Times

Sep. 27, 2010

Insulin manufacturer Novo Nordisk will challenge a claim by the Federal Anti-Monopoly Service that it violated competition rules, Katrine Sperling, a spokeswoman for the Denmark-based company, said Monday.

“We have decided to challenge their decision in Moscow’s Court of Arbitration,” Sperling said.

If Novo Nordisk loses, the company could be fined as much as 15 percent of its Russian sales, the anti-monopoly agency said Friday.

(Bloomberg)

… we have a small favor to ask.

As you may have heard, The Moscow Times, an independent news source for over 30 years, has been unjustly branded as a "foreign agent" by the Russian government. This blatant attempt to silence our voice is a direct assault on the integrity of journalism and the values we hold dear.

We, the journalists of The Moscow Times, refuse to be silenced. Our commitment to providing accurate and unbiased reporting on Russia remains unshaken. But we need your help to continue our critical mission.

Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just 2. It's quick to set up, and you can be confident that you're making a significant impact every month by supporting open, independent journalism. Thank you.

Continue